Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business Research Store is run by Sector Publishing Intelligence Ltd. SPi has been selling professional market research reports and company analyses for over 7 years. Our experienced staff team are on hand to help with any research enquiries you may have, and help you find the right report for your needs. We sell reports to businesses of all sizes across the world who need current market data to plan and develop their business strategies. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1305 753769 or Email: office@sectorpublishing.com 2
Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-term continuous management of pain. It offers fast track designation from FDA for Xtampza ER in pain management. The company's other pipeline products comprise COL-172 oxymorphone, COL-195 hydrocodone and COL-196 morphine, and COL-171 methylphenidate. It collaborates with organizations for product licensing, and technology development opportunities. Collegium is headquartered in Canton, Massachusetts, the US. Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. 3
- Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH45721D Number of Pages : 44 Report Format : PDF Publisher Information : 4
Table Of Contents for Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 16-04-2018] Table of Contents Table of Contents 3List of Tables 4List of Figures 4Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8Collegium Pharmaceutical Inc, Medical Devices Deals, 2012 to YTD 2018 9Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deal Details 12Venture Financing 12Collegium Pharma Raises USD50 Million in Venture Financing 12Collegium Pharma Raises US$4 Million In Venture Financing 14Collegium Pharma Raises US$22.5 Million In Series B Financing 15Licensing Agreements 16Collegium Pharma Enters into Licensing Agreement with Depomed 16Equity Offering 17Collegium Pharma Plans to Raise up to USD60 Million in Public Offering of Shares 17Collegium Pharma Raises USD92 Million in Pubic Offering of Shares 18Collegium Pharma Raises USD55 Million in Public Offering of Shares 20Collegium Pharma Raises USD80 Million in IPO 22Collegium Pharma Raises USD8 Million in Private Placement of Series C Preferred Stock 24Collegium Pharma Raises USD0.9 Million in Second Tranche of Private Placement of Series C Preferred Stock 25Collegium Pharma Raises USD3 Million in First Tranche of Private Placement of Series C Preferred Stock 26Collegium Pharmaceutical Inc - Key Competitors 27Collegium Pharmaceutical Inc - Key Employees 28Collegium Pharmaceutical Inc - Locations And Subsidiaries 29Head Office 29Other Locations & Subsidiaries 29Recent Developments 30Financial Announcements 30Mar 07, 2018: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 2017 30Nov 08, 2017: Collegium Announcers Third Quarter Financial Results and Provides Corporate Update 32Aug 09, 2017: Collegium Reports Second Quarter Financial Results and Provides Corporate Update 34May 10, 2017: Collegium Reports 2017 First Quarter Financial Results and Provides Corporate Update 36Mar 09, 2017: Collegium Reports Fourth Quarter Financial Results and Provides Corporate Update 37Corporate Communications 38May 30, 2017: Collegium Announces the Appointment of Joseph Ciaffoni as Chief Operating Officer 38Product News 3906/08/2017: Collegium Announces Scientific Presentations at the 2017 International Conference on Opioids 3906/01/2017: Collegium Announces Additional Managed Care Coverage for Xtampza ER for Medicare Part D Patients 4004/03/2017: Collegium Announces Expanded Managed Care Coverage for Xtampza ER for Medicare Part D Patients 4102/01/2017: Collegium Announces Positive Topline Results of Human Abuse Potential Clinical Trial Evaluating the Oral Abuse of Xtampza ER 42Clinical Trials 43Mar 16, 2017: Collegium Announces Scientific Presentation at American Academy of Pain Medicine 2017 Meeting 43Appendix 44Methodology 44About GlobalData 44Contact Us 44Disclaimer 44 5
List Of Tables in Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 16-04-2018] List of Tables Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Collegium Pharmaceutical Inc, Deals By Therapy Area, 2012 to YTD 2018 8 Collegium Pharmaceutical Inc, Medical Devices Deals, 2012 to YTD 2018 9 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10 Collegium Pharma Raises USD50 Million in Venture Financing 12 Collegium Pharma Raises US$4 Million In Venture Financing 14 Collegium Pharma Raises US$22.5 Million In Series B Financing 15 Collegium Pharma Enters into Licensing Agreement with Depomed 16 Collegium Pharma Plans to Raise up to USD60 Million in Public Offering of Shares 17 Collegium Pharma Raises USD92 Million in Pubic Offering of Shares 18 Collegium Pharma Raises USD55 Million in Public Offering of Shares 20 Collegium Pharma Raises USD80 Million in IPO 22 Collegium Pharma Raises USD8 Million in Private Placement of Series C Preferred Stock 24 Collegium Pharma Raises USD0.9 Million in Second Tranche of Private Placement of Series C Preferred Stock 25 Collegium Pharma Raises USD3 Million in First Tranche of Private Placement of Series C Preferred Stock 26 Collegium Pharmaceutical Inc, Key Competitors 27 Collegium Pharmaceutical Inc, Key Employees 28 Collegium Pharmaceutical Inc, Subsidiaries 29 6
List Of Figures, Charts and Diagrams in Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 16-04-2018] List of Figures Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7 Collegium Pharmaceutical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8 Collegium Pharmaceutical Inc, Medical Devices Deals, 2012 to YTD 2018 9 7
How to Buy... Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Updated: 16-04-2018] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at office@sectorpublishing.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1305 753769 We will be delighted to give you our personal attention. 8